A core outcome set for clinical trials in acute diarrhoea

被引:35
作者
Karas, Jacek [1 ]
Ashkenazi, Shai [2 ,3 ]
Guarino, Alfredo [4 ]
Lo Vecchio, Andrea [4 ]
Shamir, Raanan [5 ,6 ]
Vandenplas, Yvan [7 ]
Szajewska, Hania [1 ]
机构
[1] Med Univ Warsaw, Dept Paediat, PL-01184 Warsaw, Poland
[2] Schneider Childrens Med Ctr, Petah Tiqwa, Israel
[3] Tel Aviv Univ, Sackler Fac Med, Felsenstein Med Res Ctr, IL-69978 Tel Aviv, Israel
[4] Univ Naples Federico II, Sect Pediat, Dept Translat Med Sci, Naples, Italy
[5] Schneider Childrens Med Ctr, Inst Gatroenterol Nutr & Liver Dis, Petah Tiqwa, Israel
[6] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
[7] Vrije Univ Brussel, UZ Brussel, Dept Pediat, Brussels, Belgium
关键词
D O I
10.1136/archdischild-2014-307403
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective Core outcome sets are the baseline for what should be measured in clinical research and, thus, should serve as a guide for what should be collected and reported. The Consensus Group on Outcome Measures Made in Pediatric Enteral Nutrition Clinical Trials, established in 2012, agreed that consensus on a core set of outcomes with agreed-upon definitions that should be measured and reported in clinical trials was needed. To achieve this goal, six working groups (WGs) were setup, including WG on acute diarrhoea, whose main goal was to develop a core outcome set for trials in acute diarrhoea. Methods The first step identified how published outcomes related to acute diarrhoea were reported. The second focused on the methodology for determining which outcomes to measure in clinical trials. The third employed a two-phase questionnaire study using the Delphi technique to define clinically important outcomes to clinicians and parents. Results For therapeutic studies, the five most important outcome measures were diarrhoea duration, degree of dehydration, need for hospitalisation (or duration of hospitalisation for inpatients), the proportion of patients recovered by 48 h and adverse effects. The prophylactic core outcome set included prevention of diarrhoea, prevention of dehydration, prevention of hospitalisation and adverse effects. Conclusions The outcome sets for therapy and prevention can be recommended for use in future trials of patients with gastroenteritis. Their envisioned goal is to decrease study heterogeneity and to ease the comparability of studies. WG's next step is to determine how to measure the outcomes included in the core set.
引用
收藏
页码:359 / U79
页数:5
相关论文
共 9 条
  • [1] Dalkey NC, 1969, DELPHI METHOD EXPT S
  • [2] Measurement Issues in Trials of Pediatric Acute Diarrheal Diseases: A Systematic Review
    Johnston, Bradley C.
    Shamseer, Larissa
    da Costa, Bruno R.
    Tsuyuki, Ross T.
    Vohra, Sunita
    [J]. PEDIATRICS, 2010, 126 (01) : E222 - E231
  • [3] Kirwan John R, 2005, J Rheumatol, V32, P2250
  • [4] Koletzko B, 2012, ANN NUTR METAB, V60, P179, DOI [10.1159/000338803, 10.1159/000337681]
  • [5] Sinha I, 2008, PLOS MED, V29, P5
  • [6] Development of a core outcome set for clinical trials in childhood asthma: a survey of clinicians, parents, and young people
    Sinha, Ian P.
    Gallagher, Ruairi
    Williamson, Paula R.
    Smyth, Rosalind L.
    [J]. TRIALS, 2012, 13
  • [7] OMERACT: An international initiative to improve outcome measurement in rheumatology
    Tugwell, Peter
    Boers, Maarten
    Brooks, Peter
    Simon, Lee
    Strand, Vibeke
    Idzerda, Leanne
    [J]. TRIALS, 2007, 8 (1)
  • [8] Driving up the quality and relevance of research through the use of agreed core outcomes
    Williamson, Paula
    Altman, Douglas
    Blazeby, Jane
    Clarke, Michael
    Gargon, Elizabeth
    [J]. JOURNAL OF HEALTH SERVICES RESEARCH & POLICY, 2012, 17 (01) : 1 - 2
  • [9] Yousuf MI, PRACT ASSESS RES EVA, V12